A high frequency of point mutations at codon 12 of the Ki-ras gene has previously been reported for rat kidney mesenchymal tumors induced by methylating N-nitroso compounds. In this study, we analyzed renal tumors with divergent histogenesis, i.e., mesenchymal tumors (sarcomas), cortical epithelial
Activating point mutation in Ki-ras codon 63 in a chemically induced rat renal tumor
✍ Scribed by Kathleen G. Higinbotham; Jerry M. Rice; Alan O. Perantoni
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 398 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Renal mesenchymal tumors induced in F344 rats with methyl(methoxymethyl)nitrosamine (DMN‐OMe) have previously been shown by our laboratory to contain transforming Ki‐ras sequences, activated most commonly by a variety of codon 12 mutations. Further sequence analysis of one DMN‐OMe‐induced tumor with transforming Ki‐ras sequences detected by NIH 3T3 transfection assay but with no mutation in codon 12 detected by selective oligonucleotide hybridization has now revealed an activating point mutation in codon 63. The observed GAG→AAG transition in codon 63, which replaces glutamic acid with lysine, was the only detectable mutation in exon 1 and 2 hotspot regions of Ki‐ras in this tumor. The same mutation was also detected in Ki‐ras sequences derived from first‐ and second‐cycle transformants in NIH 3T3 transfection assays. Although random mutagene‐sis studies of cloned Ha‐ras sequences by Fasano et al. (Proc Natl Acad Sci USA 81:4008–4012, 1984) had already indicated that GAG→AAG mutations in codon 63 of ras are transforming, this is the first demonstration of the natural occurrence of this particular activating mutation in a tumor. © 1992 wiley‐List, Inc.
📜 SIMILAR VOLUMES
## Abstract We have used the polymerase chain reaction and dideoxynucleotide sequencing to amplify and sequence exons 1 and 2 of the c‐Ki‐__ras__ proto‐oncogene from the normal Syrian golden hamster. Similar methods were employed to screen for the presence of point mutations in the c‐Ki‐__ras__ onc